Study finds type 1 diabetes may account for 8% of diabetes cases in young adults.

American Diabetes Association symposium presents new phase 3 clinical trials of SURPASS-3 and SURPASS-5. 

Researchers assess the safety of intranasal insulin as a treatment for type 2 diabetes-associated cognitive impairment in aging adult populations. 

The internet has many different opinions of what an optimal diet is for athletes, but what do the experts say?
With exclusive commentary from Sheri Colberg, PhD.

Dapagliflozin has shown clinical effectiveness in some of the same metabolic processes that are affected by COVID-19, but can it help treat patients who have contracted the virus?

The prevalence of underdiagnosed prediabetes and type 2 diabetes mellitus (T2DM) plays an active role in gestational diabetes.

Real-world data for the Medtronic Extended-Wear Infusion Set revealed at the 81st American Diabetes Association scientific session.

American Diabetes Association mini-symposium presented by Biykem Bozkurt, MD, Ph.D., FHFSA, FACC, FAHA, FESC. 

The GRADE Study is the most comprehensive study comparing multiple diabetic medications to assess efficacy in type 2 diabetes. So which drug therapy reigned supreme?

The study evaluates the healthcare cost associated with two principal therapies for patients with type 2 diabetes.